Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders.
about
The role of lamotrigine in the management of bipolar disorderDifferences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella reviewAn overview of recent findings of the Stanley Foundation Bipolar Network (Part I).Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.Clinical predictors of ketamine response in treatment-resistant major depression.Recent developments in the treatment of bipolar disorders.Newer anticonvulsant drugs in neuropathic pain and bipolar disorder.Behavioural effects of the newer antiepileptic drugs: an update.Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders.Neurobiology of seizures and behavioral abnormalities.Combined biological tests for suicide predictionGABA and glutamate systems as therapeutic targets in depression and mood disorders.Gabapentin Therapy in Psychiatric Disorders: A Systematic Review.A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials.Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysisLamotrigine in the treatment of unipolar depression with and without comorbidities: a literature review.Understanding the pharmacokinetics of anxiolytic drugs.Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunctionNovel glutamatergic drugs for the treatment of mood disorders.Is duration of illness really influencing outcome in major psychoses?The 'disconnect' between initial judgments of lamotrigine vs. its real-world effectiveness in managing bipolar disorder. A tale with wider ramifications.Areas of controversy in neuroprogression in bipolar disorder.Neuroprogression and illness trajectories in bipolar disorder.Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine.A factor analytic study in bipolar depression, and response to lamotrigine.Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.
P2860
Q24658110-FBC228AC-C7D2-4B0C-817D-968D57F893A6Q28474985-32A8399F-B7C7-4795-85A3-EFDF9E12A76BQ30482552-E3FCE3CD-D674-4B6F-96AB-D7B98264E68CQ34146222-D259C88C-F7C7-452A-B037-A0587AA87FE5Q35026766-AA3CBE52-E2E4-47A0-9C15-C420B1D11DDEQ35547289-CFF880C8-C464-4282-9D89-3FEA06BC60ECQ35592152-CDFB20E1-FAF2-4B1C-9241-429AA0F71B9FQ35609738-33FC7A68-0C29-4518-9216-547E63ED0A43Q35757918-1ECE04A2-9FFA-45A2-8C44-5A620CEE79F8Q35798223-E03450E5-FEE9-48AA-9E75-2BEB4971A245Q35819349-35699E1D-B9B7-4E35-B90D-BFA324765C2AQ36066308-911ACD89-D5A0-41DF-B33F-C74FC56D53ADQ36518678-CECA25E9-4291-4434-A3E6-E503262B1D55Q36560064-22112F29-F5F1-4325-BF8D-79245E749A8AQ36606791-D6F6B657-9E7E-44B3-B428-FBB2D2453C92Q36936379-DEF57E1C-CE02-4CA3-A4AB-7B10CD6587D6Q37728271-914A7238-7AB9-469A-A7B1-92F3A9240BDEQ37983019-44DB90C8-09D0-4FCA-ACA2-5971D4045E71Q38075049-4F12F923-35B0-49C0-816C-6CEC3D8047EAQ38125568-0F89D722-3A5D-440B-9008-3763D2A6EAF9Q38131480-A1A12665-3EE2-4068-A026-01C7FDBA8212Q38376655-A94B5595-AD31-4623-8103-D724B20930E6Q38442319-1908632D-8068-499C-9C75-C74B1A428C87Q38812942-E190165A-84EF-409C-AABB-899DF16570E2Q38962191-4BE41AD7-1C4C-4919-883F-882ED8C06E03Q39006965-96C8601B-2746-4E5F-8073-91BF70695CC7Q44393870-E16F8D09-1056-4A14-B3BD-99F878232874Q48176000-16FF3D5B-6EB5-4171-A43D-AB19F0D6B472Q52645820-DED524A2-C222-4F3F-B0D6-02FB5BE28189
P2860
Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Clinical predictors of respons ...... efractory affective disorders.
@en
type
label
Clinical predictors of respons ...... efractory affective disorders.
@en
prefLabel
Clinical predictors of respons ...... efractory affective disorders.
@en
P2093
P1476
Clinical predictors of respons ...... efractory affective disorders.
@en
P2093
Andrew M Speer
David A Luckenbaugh
Elizabeth A Osuch
Gabriela V Obrocea
Gabriele S Leverich
Kamal Jajodia
Mark A Frye
Robert M Dunn
Robert M Post
P304
P356
10.1016/S0006-3223(01)01206-9
P407
P577
2002-02-01T00:00:00Z